What is the ticker symbol for BioAge Labs?

BioAge Labs trades under the ticker BIOA on NASDAQ.

What sector does BioAge Labs operate in?

BioAge Labs is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze BIOA in a portfolio?

PortView shows BIOA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

BioAge Labs (BIOA) Stock Analysis

NASDAQHealthcareBiotechnology

$9.60+0.84%

1-year price historyRange $4.71 – $25.10

52-week range$9.60

$4.55$25.96

What BioAge Labs does

BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company’s technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally available brain-penetrant small-molecule NLRP3 inhibitor which is in Phase 1 clinical trail for the treatment of atherosclerotic cardiovascular disease, as well as for the treatment of diabetic macular edema and geographic atrophy; and develops APJ agonists for obesity, including programs targeting both oral and parenteral administration. The company has collaboration agreement with Novartis Pharma AG to identify and validate novel therapeutic drug targets by investigating the biological mechanisms that drive diseases related to aging and mediate. BioAge Labs, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.

Key metrics

Market cap

$361.44M

P/E (TTM)

-4.03

EPS (TTM)

$-2.38

Beta

0.93

Dividend yield

0.00%

Revenue / share

$0.23

50-day avg

$17.25

200-day avg

$16.90

52-week high

$25.96

52-week low

$4.55

CEO

Kristen Fortney

ETFs linked to BIOA

Broad-market and Healthcare sector ETFs an investor holding BioAge Labs is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how BIOA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze BIOA in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for BioAge Labs?: BioAge Labs trades under the ticker BIOA on NASDAQ.
Which exchange is BIOA listed on?: BIOA is listed on NASDAQ.
What sector does BioAge Labs operate in?: BioAge Labs is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze BIOA in a portfolio?: PortView shows BIOA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.